Fertility test is an important part of fertility treatment and evaluation. By fertility testing, the healthcare professional can possibly determine what's preventing a couple from achieving pregnancy. Fertility tests proved various benefits such as measurement of important reproductive hormones, detection of possible fertility issues, and many others. Fertility test can be done using various fertility testing products such as ovulation prediction kits, fertility monitors, transvaginal ultrasound and many others.
The North America fertility test market has been driven by several driving factors. The primary factor behind the growth of the market is increasing infertility disorder in both female and male and changing lifestyle of the population across the region. Likewise, factors such as increasing median age of first-time pregnancies in women and development and launches of advanced, innovative and easy-to-use ovulation prediction kits across the region, rising preference for accessibility & confidentiality of test results, and quick results of diagnosis are likely to create more opportunities for the North America fertility testing market over the forecast period.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the fertility test market. In addition, complete analysis of changes on fertility test market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increasing number of unplanned pregnancies during the COVID-19 pandemic has created more demand for fertility testing kits or products, this has affected positively on the market.
The study analyses North America fertility test market based on product, mode of purchase, application, end user, and country.
Various products such as ovulation prediction kits, fertility monitors, and male fertility testing products are covered in the North America fertility test market report. The fertility monitors segment is further bifurcated into urine-based ovulation kits, saliva-based ovulation kits, blood-based ovulation kits and other fertility monitors. The ovulation prediction kits segment dominated the market in past few years. However, the market for fertility monitors segment is expected to witness rapid growth during the forecast period. An increasing production and adoption of urine-based ovulation kits and saliva-based ovulation kits, surged demand for at-home women fertility testing kits and surge in the number of product developments and launches by the global manufacturing companies are some of the major factors that attributed to the growth of the fertility monitors segment.
Based on mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products and online products. The OTC-based products segment is accounted for the major market share in 2020. Nevertheless, online products segment is expected to observe lucrative growth in the coming years. Major factors such as an increasing purchase of male and female fertility testing kits via over-the-counter mode, rising number of unwanted pregnancy among young population and surged demand for at-home male fertility testing kits to avoid in office semen analysis process are accredited to the growth of the segment.
The North America fertility test market finds applications in female fertility products and male fertility products. The male fertility products segment is accounted for the second-largest market share in 2020. Male fertility testing involves semen testing or analysis and genetic testing. Semen can be tested by using sperm analyzers for sperm motility, sperm count, sperm morphology, volume, pH, acrosome activity and fructose content. Increasing production of products such as sperm processing equipment, sperm analyzers and many other testing kits is supporting the growth of the market.
The end users covered in North America fertility test market are home care settings, hospitals and fertility clinics and other end users. Home care setting segment is projected to witness rapid growth during the estimation period. Key factors attributed to the segment growth are the massive availability of at-home fertility testing kits and apps and increasing introduction of AI and other advanced technologies in fertility testing kits to make at-home fertility test more effective.
Country wise, the study is comprised of the key countries such as the US, Canada, and Mexico. The US held the largest market share of North America fertility test market and is likely to dominate the market over the estimated time frame. Increasing cases related to infertility across the country is likely to improve growth of the market. For instance, according to CDC, in the United States, approximately 6% of married women aged between 15 to 44 years are unable to get pregnant after one year of trying. Also, nearly 12% of women aged 15 to 44 years in the country have complexities getting pregnant or carrying a pregnancy to term.
The major key players of market includes Advacare Pharma, Ava, Babystart (Snowden Healthcare), Biozhena, Church & Dwight, Exseed Health, Fairhaven Health, Fertility Focus, Geratherm Medical, Hilin Life Products, Medical Electronic Systems, Mira Care, Pregmate, Prestige Brands Holdings, Sensiia, Swim Count (Subsidiary Of Motiltycount Aps), Swiss Precision Diagnostics, Tempdrop, Uebe Medical and Valley Electronics among others.
The study analyses North America fertility test market based on purchase, application, end user, and country. Fertility Test market by product is segmented into ovulation prediction kits, fertility monitors, and male fertility testing products. The ovulation prediction kits segment is likely to dominate the market over the forecast period. Increased adoption of ovulation prediction kits owing to its several benefits such as low cost is attributed to the market growth. By mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products, and online products. The market finds application in female fertility products and male fertility products. The female fertility products segment is likely to register fastest growth in years to come owing to the growing adoption of female fertility products owing to its easy availability. By mode of end user, the market is segmented into home care settings, hospitals and fertility clinics and other end users. Country wise, the study is comprised of the key countries such as the US, Canada and Mexico.
Why to buy this report: